Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy
出版年份 2020 全文链接
标题
Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-03
DOI
10.1111/dom.14042
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
- (2019) Darren K. McGuire et al. CIRCULATION
- Heart Failure in Type 2 Diabetes Mellitus
- (2019) Helena C. Kenny et al. CIRCULATION RESEARCH
- The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
- (2019) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Heart Failure in the diabetic patient – epidemiology, etiology, prognosis, therapy and the effect of glucose lowering medications
- (2019) David S.H. Bell et al. DIABETES OBESITY & METABOLISM
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care
- (2019) Elisabetta Patorno et al. CIRCULATION
- Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
- (2019) Shannon M. Dunlay et al. CIRCULATION
- The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
- (2019) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) James L. Januzzi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction
- (2019) Yevgeniy Khariton et al. JACC-Heart Failure
- The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
- (2019) Dhiren K. Patel et al. Diabetes Therapy
- Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
- (2019) Alexandra C. Villasante Fricke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Future of Wearables in Heart Failure Patients
- (2019) Adam D. DeVore et al. JACC-Heart Failure
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction
- (2019) Nicholas Y. Tan et al. JACC-Heart Failure
- An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction
- (2018) Dana Drzayich Antol et al. ADVANCES IN THERAPY
- Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial
- (2018) Petr Jarolim et al. DIABETES CARE
- Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review
- (2018) Karin Rådholm et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure
- (2018) Milton Packer EUROPEAN JOURNAL OF HEART FAILURE
- Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases
- (2018) Susanna C. Larsson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
- (2018) Motoaki Sano Journal of Cardiology
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function
- (2018) Isabelle Johansson et al. Diabetes & Vascular Disease Research
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
- (2018) Yixing Li et al. Current Cardiology Reports
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
- (2018) Sandeep R. Das et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
- (2017) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
- (2017) Vance B. Matthews et al. JOURNAL OF HYPERTENSION
- The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
- (2017) Jens Jordan et al. Journal of the American Society of Hypertension
- A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis
- (2017) Sandra Korol et al. MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study
- (2017) Bryan Wilner et al. Journal of the American Heart Association
- Sacubitril/valsartan in PARADIGM-HF
- (2017) Nicolas Vodovar et al. Lancet Diabetes & Endocrinology
- Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?
- (2017) Gregory Giamouzis et al. Lancet Diabetes & Endocrinology
- Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
- (2017) Jelena P Seferovic et al. Lancet Diabetes & Endocrinology
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis
- (2017) Chunguang Chen et al. Molecular Metabolism
- Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
- (2017) Jacob A. Udell et al. CIRCULATION
- Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
- (2016) Zhanna Kobalava et al. Cardiovascular Therapeutics
- Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes
- (2016) Eberhard Standl et al. CIRCULATION RESEARCH
- Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Søren L. Kristensen et al. Circulation-Heart Failure
- Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension
- (2016) J Jordan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
- (2016) Subodh Verma et al. DIABETES CARE
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
- (2016) Javier Díez EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial
- (2016) Azmil H. Abdul-Rahim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2016) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
- (2015) Faiez Zannad et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
- (2015) Alessandra Dei Cas et al. JACC-Heart Failure
- Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
- (2014) Robert J. Mentz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Advanced Glycation End Products and Diabetic Complications
- (2014) Varun Parkash Singh et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
- (2014) Orly Vardeny et al. JACC-Heart Failure
- Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes?
- (2013) Lindsey Duca et al. Current Diabetes Reports
- Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact
- (2013) John J. V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Congestive Heart Failure and Diabetes Mellitus: Balancing Glycemic Control with Heart Failure Improvement
- (2012) Saifullah Nasir et al. AMERICAN JOURNAL OF CARDIOLOGY
- Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction
- (2012) Finlay A. McAlister et al. Circulation-Heart Failure
- Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity
- (2012) Marcelo A. Mori et al. PLoS One
- Optimization of Cardiac Metabolism in Heart Failure
- (2011) Tomohisa Nagoshi et al. CURRENT PHARMACEUTICAL DESIGN
- Valsartan Improves -Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism: A randomized controlled trial
- (2011) N. J. van der Zijl et al. DIABETES CARE
- Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease
- (2011) Stergios A Polyzos et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Impact of diabetes mellitus on quality of life in patients with congestive heart failure
- (2011) Buntaro Fujita et al. QUALITY OF LIFE RESEARCH
- Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: A meta-analysis of 59,862 patients
- (2010) Deng-feng Geng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
- Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases
- (2008) S. Rubattu et al. AMERICAN JOURNAL OF HYPERTENSION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now